Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/13938
Full metadata record
DC FieldValueLanguage
dc.contributor.authorUeda J.-Y.
dc.contributor.authorAthikomkulchai S.
dc.contributor.authorMiyatake R.
dc.contributor.authorSaiki I.
dc.contributor.authorEsumi H.
dc.contributor.authorAwale S.
dc.date.accessioned2021-04-05T03:32:43Z-
dc.date.available2021-04-05T03:32:43Z-
dc.date.issued2013
dc.identifier.issn11778881
dc.identifier.other2-s2.0-84890483880
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/13938-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84890483880&doi=10.2147%2fDDDT.S52168&partnerID=40&md5=ea6c9d63fff69e92ea9ba0f531c0a455
dc.description.abstractHuman pancreatic tumors are known to be highly resistant to nutrient starvation, and this prolongs their survival in the hypovascular (austere) tumor microenvironment. Agents that retard this tolerance to nutrient starvation represent a novel antiausterity strategy in anticancer drug discovery. (+)-Grandiforacin (GF), isolated from Uvaria dac, has shown preferential toxicity to PANC-1 human pancreatic cancer cells under nutrient starvation, with a PC50 value of 14.5 μM. However, the underlying mechanism is not clear. In this study, GF was found to preferentially induce PANC-1 cell death in a nutrient-deprived medium via hyperactivation of autophagy, as evidenced by a dramatic upregulation of microtubule-associated protein 1 light chain 3. No change was observed in expression of the caspase-3 and Bcl-2 apoptosis marker proteins. GF was also found to strongly inhibit the activation of Akt, a key regulator of cancer cell survival and proliferation. Because pancreatic tumors are highly resistant to current therapies that induce apoptosis, the alternative cell death mechanism exhibited by GF provides a novel therapeutic insight into antiausterity drug candidates. © 2014 Ueda et al.
dc.subjectamino acid
dc.subjectantineoplastic agent
dc.subjectcamptothecin
dc.subjectcaspase 3
dc.subjectdeoxyglucose
dc.subjectfluorouracil
dc.subjectgemcitabine
dc.subjectglucose
dc.subjectGrandifloracin
dc.subjectmammalian target of rapamycin
dc.subjectpaclitaxel
dc.subjectplant extract
dc.subjectpodophyllotoxin
dc.subjectprotein bcl 2
dc.subjectunclassified drug
dc.subjectbridged compound
dc.subjectgrandifloracin
dc.subjectprotein kinase B
dc.subjecttarget of rapamycin kinase
dc.subjectAKT kinase assay
dc.subjectapoptosis
dc.subjectarticle
dc.subjectautophagy
dc.subjectcancer cell
dc.subjectcancer cell culture
dc.subjectcancer resistance
dc.subjectcell assay
dc.subjectcell death
dc.subjectcell proliferation
dc.subjectcell structure
dc.subjectcell survival
dc.subjectcell viability
dc.subjectcomparative effectiveness
dc.subjectconcentration response
dc.subjectcontrolled study
dc.subjectcytotoxicity
dc.subjecthuman
dc.subjecthuman cell
dc.subjectin vitro study
dc.subjectPANC 1 cell line
dc.subjectpancreas cancer
dc.subjectpancreas tumor
dc.subjectpharmacodynamics
dc.subjectprotein expression
dc.subjectprotein phosphorylation
dc.subjectstarvation
dc.subjectupregulation
dc.subjectUvaria
dc.subjectWestern blotting
dc.subjectantagonists and inhibitors
dc.subjectdose response
dc.subjectdrug effects
dc.subjectPancreatic Neoplasms
dc.subjectpathology
dc.subjecttumor cell line
dc.subjectApoptosis
dc.subjectAutophagy
dc.subjectBridged Compounds
dc.subjectCell Line, Tumor
dc.subjectDose-Response Relationship, Drug
dc.subjectHumans
dc.subjectPancreatic Neoplasms
dc.subjectProto-Oncogene Proteins c-akt
dc.subjectTOR Serine-Threonine Kinases
dc.title(+)-Grandiforacin, an antiausterity agent, induces autophagic PANC-1 pancreatic cancer cell death
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationDrug Design, Development and Therapy. Vol 8, (2013), p.39-47
dc.identifier.doi10.2147/DDDT.S52168
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.